Guy C. Brown
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Guy C. Brown has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Vilmante Borutaite
5 shared publications- Aistė Jekabsone
Preclinical Research Laboratory for Medicinal Products, Institute of Cardiology, Lithuanian University of Health Sciences, Kaunas, Lithuania
3 shared publications Jonas J. Neher
3 shared publicationsSalvador Moncada
Wolfson Institute for Biomedical Research, University College London, London, United Kingdom
2 shared publicationsAnna Bal-Price
University of Cambridge
1 shared publication- Anna Tickler
Cavendish Laboratory, University of Cambridge, Cambridge CB3 0HE, UK
1 shared publication
Latest Publications
- Open Access
- 13 August 2012
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 9 (1) , 196
Primary phagocytosis of viable neurons by microglia activated with LPS or Aβ is dependent on calreticulin/LRP phagocytic signalling
Microglia are resident brain macrophages that can phagocytose dead, dying or viable neurons, which may be beneficial or detrimental in inflammatory, ischaemic and neurodegenerative brain pathologies. Cell death caused by phagocytosis of an otherwise viable cell is called ‘primary phagocytosis’ or ‘phagoptosis’. Calreticulin (CRT) exposure on the surface of cancer cells can promote their phagocytosis via LRP (low-density lipoprotein receptor-related protein) on macrophages, but it is not known whether this occurs with neurons and microglia.
- 13 August 2012
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 9 (1) , 196
Open AccessPrimary phagocytosis of viable neurons by microglia activated with LPS or Aβ is dependent on calreticulin/LRP phagocytic signalling
Microglia are resident brain macrophages that can phagocytose dead, dying or viable neurons, which may be beneficial or detrimental in inflammatory, ischaemic and neurodegenerative brain pathologies. Cell death caused by phagocytosis of an otherwise viable cell is called ‘primary phagocytosis’ or ‘phagoptosis’. Calreticulin (CRT) exposure on the surface of cancer cells can promote their phagocytosis via LRP (low-density lipoprotein receptor-related protein) on macrophages, but it is not known whether this occurs with neurons and microglia.
- 1 August 2012
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 37 (8) , 325-332
Eaten alive! Cell death by primary phagocytosis: ‘phagoptosis’
- 1 August 2012
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 37 (8) , 325-332
Eaten alive! Cell death by primary phagocytosis: ‘phagoptosis’
- Open Access
- 1 January 2012
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 3, 27
Primary Phagocytosis of Neurons by Inflamed Microglia: Potential Roles in Neurodegeneration
Microglial phagocytosis of dead or dying neurons can be beneficial by preventing the release of damaging and/or pro-inflammatory intracellular components. However, there is now evidence that under certain conditions, such as inflammation, microglia can also phagocytose viable neurons, thus executing their death. Such phagocytic cell death may result from exposure of phosphatidylserine (PS) or other eat-me signals on otherwise viable neurons as a result of physiological activation or sub-toxic insult, and neuronal phagocytosis by activated microglia. In this review, we discuss the mechanisms of phagocytic cell death and its potential roles in Alzheimer’s Disease, Parkinson’s Disease, and Frontotemporal Dementia.
- 1 January 2012
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 3, 27
Open AccessPrimary Phagocytosis of Neurons by Inflamed Microglia: Potential Roles in Neurodegeneration
Microglial phagocytosis of dead or dying neurons can be beneficial by preventing the release of damaging and/or pro-inflammatory intracellular components. However, there is now evidence that under certain conditions, such as inflammation, microglia can also phagocytose viable neurons, thus executing their death. Such phagocytic cell death may result from exposure of phosphatidylserine (PS) or other eat-me signals on otherwise viable neurons as a result of physiological activation or sub-toxic insult, and neuronal phagocytosis by activated microglia. In this review, we discuss the mechanisms of phagocytic cell death and its potential roles in Alzheimer’s Disease, Parkinson’s Disease, and Frontotemporal Dementia.
- 1 September 2011
- Published by Springer Nature in Pharmacological Reports
- Vol. 63 (5) , 1270
Eaten alive: neuronal death by microglial phagocytosis during inflammatory neurodegeneration
- 1 September 2011
- Published by Springer Nature in Pharmacological Reports
- Vol. 63 (5) , 1270
Eaten alive: neuronal death by microglial phagocytosis during inflammatory neurodegeneration
- 1 November 2010
- Published by Elsevier in Nitric Oxide
- Vol. 23 (3) , 153-165
Nitric oxide and neuronal death
- 1 November 2010
- Published by Elsevier in Nitric Oxide
- Vol. 23 (3) , 153-165
Nitric oxide and neuronal death
- 24 September 2010
- Published by Portland Press Ltd. in Biochemical Society Transactions
- Vol. 38 (5) , 1210-1214
The principle of sufficiency and the evolution of control: using control analysis to understand the design principles of biological systems
Control analysis can be used to try to understand why (quantitatively) systems are the way that they are, from rate constants within proteins to the relative amount of different tissues in organisms. Many biological parameters appear to be optimized to maximize rates under the constraint of minimizing space utilization. For any biological process with multiple steps that compete for control in series, evolution by natural selection will tend to even out the control exerted by each step. This is for two reasons: (i) shared control maximizes the flux for minimum protein concentration, and (ii) the selection pressure on any step is proportional to its control, and selection will, by increasing the rate of a step (relative to other steps), decrease its control over a pathway. The control coefficient of a parameter P over fitness can be defined as (∂N/N)/(∂P/P), where N is the number of individuals in the population, and ∂N is the change in that number as a result of the change in P. This control coefficient is equal to the selection pressure on P. I argue that biological systems optimized by natural selection will conform to a principle of sufficiency, such that the control coefficient of all parameters over fitness is 0. Thus in an optimized system small changes in parameters will have a negligible effect on fitness. This principle naturally leads to (and is supported by) the dominance of wild-type alleles over null mutants.
- 24 September 2010
- Published by Portland Press Ltd. in Biochemical Society Transactions
- Vol. 38 (5) , 1210-1214
The principle of sufficiency and the evolution of control: using control analysis to understand the design principles of biological systems
Control analysis can be used to try to understand why (quantitatively) systems are the way that they are, from rate constants within proteins to the relative amount of different tissues in organisms. Many biological parameters appear to be optimized to maximize rates under the constraint of minimizing space utilization. For any biological process with multiple steps that compete for control in series, evolution by natural selection will tend to even out the control exerted by each step. This is for two reasons: (i) shared control maximizes the flux for minimum protein concentration, and (ii) the selection pressure on any step is proportional to its control, and selection will, by increasing the rate of a step (relative to other steps), decrease its control over a pathway. The control coefficient of a parameter P over fitness can be defined as (∂N/N)/(∂P/P), where N is the number of individuals in the population, and ∂N is the change in that number as a result of the change in P. This control coefficient is equal to the selection pressure on P. I argue that biological systems optimized by natural selection will conform to a principle of sufficiency, such that the control coefficient of all parameters over fitness is 0. Thus in an optimized system small changes in parameters will have a negligible effect on fitness. This principle naturally leads to (and is supported by) the dominance of wild-type alleles over null mutants.
- 31 July 2010
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Bioenergetics
- Vol. 1797, 74
The brain in flames: Mitochondria in inflammatory neurodegeneration
- 31 July 2010
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Bioenergetics
- Vol. 1797, 74
The brain in flames: Mitochondria in inflammatory neurodegeneration
- 2 March 2010
- Published by Springer Nature in Molecular Neurobiology
- Vol. 41 (2-3) , 242-247
Inflammatory Neurodegeneration and Mechanisms of Microglial Killing of Neurons
Inflammatory neurodegeneration contributes to a wide variety of brain pathologies. A number of mechanisms by which inflammatory-activated microglia and astrocytes kill neurons have been identified in culture. These include: (1) acute activation of the phagocyte NADPH oxidase (PHOX) found in microglia, (2) expression of the inducible nitric oxide synthase (iNOS) in glia, and (3) microglial phagocytosis of neurons. Activation of PHOX (by cytokines, β-amyloid, prion protein, lipopolysaccharide, ATP, or arachidonate) causes microglial proliferation and inflammatory activation; thus, PHOX is a key regulator of inflammation. However, activation of PHOX alone causes little or no death, but when combined with iNOS expression results in apparent apoptosis via peroxynitrite production. Nitric oxide (NO) from iNOS expression also strongly synergizes with hypoxia to induce neuronal death because NO inhibits cytochrome oxidase in competition with oxygen, resulting in glutamate release and excitotoxicity. Finally, microglial phagocytosis of these stressed neurons may contribute to their loss.
- 2 March 2010
- Published by Springer Nature in Molecular Neurobiology
- Vol. 41 (2-3) , 242-247
Inflammatory Neurodegeneration and Mechanisms of Microglial Killing of Neurons
Inflammatory neurodegeneration contributes to a wide variety of brain pathologies. A number of mechanisms by which inflammatory-activated microglia and astrocytes kill neurons have been identified in culture. These include: (1) acute activation of the phagocyte NADPH oxidase (PHOX) found in microglia, (2) expression of the inducible nitric oxide synthase (iNOS) in glia, and (3) microglial phagocytosis of neurons. Activation of PHOX (by cytokines, β-amyloid, prion protein, lipopolysaccharide, ATP, or arachidonate) causes microglial proliferation and inflammatory activation; thus, PHOX is a key regulator of inflammation. However, activation of PHOX alone causes little or no death, but when combined with iNOS expression results in apparent apoptosis via peroxynitrite production. Nitric oxide (NO) from iNOS expression also strongly synergizes with hypoxia to induce neuronal death because NO inhibits cytochrome oxidase in competition with oxygen, resulting in glutamate release and excitotoxicity. Finally, microglial phagocytosis of these stressed neurons may contribute to their loss.
- Open Access
- 11 August 2009
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 16 (1) , 70
Nitric oxide protects the heart from ischemia-induced apoptosis and mitochondrial damage via protein kinase G mediated blockage of permeability transition and cytochrome c release
Background: Heart ischemia can rapidly induce apoptosis and mitochondrial dysfunction via mitochondrial permeability transition-induced cytochromecrelease. We tested whether nitric oxide (NO) can block this damage in isolated rat heart, and, if so, by what mechanisms.Methods: Hearts were perfused with 50 μM DETA/NO (NO donor), then subjected to 30 min stop-flow ischemia or ischemia/reperfusion. Isolated heart mitochondria were used to measure the rate of mitochondrial oxygen consumption and membrane potential using oxygen and tetraphenylphosphonium-selective electrodes. Mitochondrial and cytosolic cytochromeclevels were measured spectrophotometrically and by ELISA. The calcium retention capacity of isolated mitochondria was measured using the fluorescent dye Calcium Green-5N. Apoptosis and necrosis were evaluated by measuring the activity of caspase-3 in cytosolic extracts and the activity of lactate dehydrogenase in perfusate, respectively.Results: 30 min ischemia caused release of mitochondrial cytochromecto the cytoplasm, inhibition of the mitochondrial respiratory chain, and stimulation of mitochondrial proton permeability. 3 min perfusion with 50 μM DETA/NO of hearts prior to ischemia decreased this mitochondrial damage. The DETA/NO-induced blockage of mitochondrial cytochromecrelease was reversed by a protein kinase G (PKG) inhibitor KT5823, or soluble guanylate cyclase inhibitor ODQ or protein kinase C inhibitors (Ro 32-0432 and Ro 31-8220). Ischemia also stimulated caspase-3-like activity, and this was substantially reduced by pre-perfusion with DETA/NO. Reperfusion after 30 min of ischemia caused no further caspase activation, but was accompanied by necrosis, which was completely prevented by DETA/NO, and this protection was blocked by the PKG inhibitor. Incubation of isolated heart mitochondria with activated PKG blocked calcium-induced mitochondrial permeability transition and cytochromecrelease. Perfusion of non-ischemic heart with DETA/NO also made the subsequently isolated mitochondria resistant to calcium-induced permeabilisation, and this protection was blocked by the PKG inhibitor.Conclusion: The results indicate that NO rapidly protects the ischemic heart from apoptosis and mitochondrial dysfunction via PKG-mediated blockage of mitochondrial permeability transition and cytochromecrelease.
- 11 August 2009
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 16 (1) , 70
Open AccessNitric oxide protects the heart from ischemia-induced apoptosis and mitochondrial damage via protein kinase G mediated blockage of permeability transition and cytochrome c release
Background: Heart ischemia can rapidly induce apoptosis and mitochondrial dysfunction via mitochondrial permeability transition-induced cytochromecrelease. We tested whether nitric oxide (NO) can block this damage in isolated rat heart, and, if so, by what mechanisms.Methods: Hearts were perfused with 50 μM DETA/NO (NO donor), then subjected to 30 min stop-flow ischemia or ischemia/reperfusion. Isolated heart mitochondria were used to measure the rate of mitochondrial oxygen consumption and membrane potential using oxygen and tetraphenylphosphonium-selective electrodes. Mitochondrial and cytosolic cytochromeclevels were measured spectrophotometrically and by ELISA. The calcium retention capacity of isolated mitochondria was measured using the fluorescent dye Calcium Green-5N. Apoptosis and necrosis were evaluated by measuring the activity of caspase-3 in cytosolic extracts and the activity of lactate dehydrogenase in perfusate, respectively.Results: 30 min ischemia caused release of mitochondrial cytochromecto the cytoplasm, inhibition of the mitochondrial respiratory chain, and stimulation of mitochondrial proton permeability. 3 min perfusion with 50 μM DETA/NO of hearts prior to ischemia decreased this mitochondrial damage. The DETA/NO-induced blockage of mitochondrial cytochromecrelease was reversed by a protein kinase G (PKG) inhibitor KT5823, or soluble guanylate cyclase inhibitor ODQ or protein kinase C inhibitors (Ro 32-0432 and Ro 31-8220). Ischemia also stimulated caspase-3-like activity, and this was substantially reduced by pre-perfusion with DETA/NO. Reperfusion after 30 min of ischemia caused no further caspase activation, but was accompanied by necrosis, which was completely prevented by DETA/NO, and this protection was blocked by the PKG inhibitor. Incubation of isolated heart mitochondria with activated PKG blocked calcium-induced mitochondrial permeability transition and cytochromecrelease. Perfusion of non-ischemic heart with DETA/NO also made the subsequently isolated mitochondria resistant to calcium-induced permeabilisation, and this protection was blocked by the PKG inhibitor.Conclusion: The results indicate that NO rapidly protects the ischemic heart from apoptosis and mitochondrial dysfunction via PKG-mediated blockage of mitochondrial permeability transition and cytochromecrelease.
- 19 July 2008
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Bioenergetics
- Vol. 1777, S58
S10/2 Mitochondria and reversible apoptosis
- 19 July 2008
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Bioenergetics
- Vol. 1777, S58
S10/2 Mitochondria and reversible apoptosis